THE OVARIAN ACTION OF INTERLEUKIN-1 IS RECEPTOR-MEDIATED - REVERSAL BY A NATURALLY-OCCURRING INTERLEUKIN-1 RECEPTOR ANTAGONIST

被引:10
|
作者
KOKIA, E [1 ]
BENSHLOMO, I [1 ]
ADASHI, EY [1 ]
机构
[1] UNIV MARYLAND,SCH MED,DEPT OBSTET & GYNECOL,DIV REPROD ENDOCRINOL,BALTIMORE,MD 21201
关键词
INTERLEUKIN-1; INTERLEUKIN-1 RECEPTOR ANTAGONIST; OVARY; GRANULOSA; PROSTAGLANDINS;
D O I
10.1016/S0015-0282(16)57314-2
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To address indirectly the possibility that the ovarian action(s) of interleukin (IL)-1 are receptor mediated and to re-examine the recently reported proposition that the naturally occurring IL-1 receptor antagonist (IL-1ra) may in fact act in the capacity of mixed IL-1 receptor agonist/antagonist. Design: In vitro treatment of isolated granulosa cell (GC) and whole ovarian dispersates of rat origin. Results: Treatment of GC from immature rats with increasing concentrations of IL-1ra (10 to 5,000 ng/mL) proved without effect on either the basal or FSH (100 ng/mL)-supported accumulation of P. Likewise, cellular viability (as assessed by conversion of 3-[4,5-dimethylthiazol-2-yl]-2-5 diphenyltetrazolium bromide to spectrophotometrically detectable formazan) remained unaltered. However, the concomitant addition of increasing concentrations of IL-1ra (10 to 5,000 ng/mL) yielded dose-dependent reversal of the 10 ng/mL IL-1 beta-mediated inhibition of the FSH-supported accumulation of P. Similarly, the ability of IL-1 beta to exert a dose-dependent (0 to 30 ng/mL) antigonadotropic effect was attenuated progressively given the concurrent presence of increasing concentrations (1,000 and 5,000 ng/mL) of IL-1ra. Although treatment of whole ovarian dispersates with 10 ng/mL IL-1 beta resulted in a 5.4-fold increase in the accumulation of prostaglandin (PG)E(2), this effect too was all but eliminated after the concomitant addition of 5 mu g/mL IL-1ra. Conclusions: These observations support the nontoxic nature of IL-1ra, confirm its lack of agonistic activity, validate its utility as an experimental probe, and suggest that neither the basal nor the FSH-stimulated accumulation of P are subject to regulation by endogenously produced GC-derived IL-1-like activity. Moreover, these observations suggest that the ability of IL-1 beta to inhibit the gonadotropin-supported accumulation of P and to increase PGE(2) accumulation is receptor-mediated.
引用
收藏
页码:176 / 181
页数:6
相关论文
共 50 条
  • [41] Interleukin-1 alpha and interleukin-1 receptor antagonist in the urine of children with acute pyelonephritis and relation to renal scarring
    Tullus, K
    EscobarBilling, R
    Fituri, O
    Burman, LG
    Karlsson, A
    Wikstad, I
    Wretlind, B
    Brauner, A
    ACTA PAEDIATRICA, 1996, 85 (02) : 158 - 162
  • [42] Specificity of interleukin-1β-induced changes in monoamine concentrations in hypothalamic nuclei:: Blockade by interleukin-1 receptor antagonist
    MohanKumar, SMJ
    MohanKumar, PS
    Quadri, SK
    BRAIN RESEARCH BULLETIN, 1998, 47 (01) : 29 - 34
  • [43] Regulation of interleukin-1β by the interleukin-1 receptor antagonist in the glutamate-injured spinal cord:: Endogenous neuroprotection
    Liu, Song
    Xu, Guo-Ying
    Johnson, Kathia M.
    Echetebu, Clement
    Ye, Zaiming
    Hulsebosch, Claire E.
    McAdoo, David J.
    BRAIN RESEARCH, 2008, 1231 : 63 - 74
  • [44] A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling
    Korherr, C
    Hofmeister, R
    Wesche, H
    Falk, W
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (01) : 262 - 267
  • [45] Effects of scaling and root planing on the amounts of interleukin-1 and interleukin-1 receptor antagonist and the mRNA expression of interleukin-1β in gingival crevicular fluid and gingival tissues
    Yoshinari, N
    Kawase, H
    Mitani, A
    Ito, M
    Sugiishi, S
    Matsuoka, M
    Shirozu, N
    Ishihara, Y
    Bito, B
    Hiraga, M
    Arakawa, K
    Noguchi, T
    JOURNAL OF PERIODONTAL RESEARCH, 2004, 39 (03) : 158 - 167
  • [46] The interaction and kinetic analysis of interleukin-1α and soluble interleukin-1 receptor I
    Wu Baoyan
    Huang Jiadong
    Li Jing
    Song Zhao
    Wang Yanyan
    Wang Xinsheng
    Chen Qiang
    CHINESE JOURNAL OF ANALYTICAL CHEMISTRY, 2006, 34 (06) : 769 - 772
  • [47] Interleukin-1 Receptor Antagonist as Therapy for Traumatic Brain Injury
    Caroline Lindblad
    Elham Rostami
    Adel Helmy
    Neurotherapeutics, 2023, 20 : 1508 - 1528
  • [48] Interleukin-1 Receptor Antagonist as Therapy for Traumatic Brain Injury
    Lindblad, Caroline
    Rostami, Elham
    Helmy, Adel
    NEUROTHERAPEUTICS, 2023, 20 (06) : 1508 - 1528
  • [49] INTERLEUKIN-1 RECEPTOR ANTAGONIST IN HUMAN EPIDERMIS AND CULTURED KERATINOCYTES
    GRUAZCHATELLARD, D
    BAUMBERGER, C
    SAURAT, JH
    DAYER, JM
    FEBS LETTERS, 1991, 294 (1-2): : 137 - 140
  • [50] A polymorphism of the interleukin-1 receptor antagonist plays a prominent role within the interleukin-1 gene cluster in vulvar carcinogenesis
    Grimm, C
    Berger, I
    Tomovski, C
    Zeillinger, R
    Concin, N
    Leodolter, S
    Koelbl, H
    Tempfer, CB
    Hefler, LA
    GYNECOLOGIC ONCOLOGY, 2004, 92 (03) : 936 - 940